Preclinical Evaluation of the Short-Term Toxicity of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine (DHA-dFdC)

Ítems similars

• Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity
  per: Youssef W. Naguib, et al.
  Publicat: (2016-01-01)
• Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity()()
  per: Naguib, Youssef W., et al.
  Publicat: (2016)
• A solid lipid nanoparticle formulation of 4-(N)-docosahexaenoyl 2′, 2′-difluorodeoxycytidine with increased solubility, stability, and antitumor activity
  per: Valdes, Solange A., et al.
  Publicat: (2019)
• Reverse Microemulsion-Based Synthesis of (Bis)phosphonate-Metal Materials with Controllable Physical Properties: An Example Using Zoledronic Acid-Calcium Complexes
  per: Li, Xu, et al.
  Publicat: (2017)
• A Pharmacokinetic and Pharmacodynamic Evaluation of the Anti-Hepatocellular Carcinoma Compound 4-N-Carbobenzoxy-gemcitabine (Cbz-dFdC)
  per: Yilin Sun, et al.
  Publicat: (2020-05-01)